Giulia Grande1, Davide L Vetrano1, Ettore Marconi2, Elisa Bianchini2, Iacopo Cricelli2, Valeria Lovato3, Luisa Guglielmini3, Daiana Taddeo4, Stefano F Cappa5,6, Claudio Cricelli4, Francesco Lapi7. 1. Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden. 2. Health Search, Italian College of General Practitioners and Primary Care, Via del Sansovino 179, 50141, Florence, Italy. 3. Roche S.P.A, Monza, Italy. 4. Italian College of General Practitioners and Primary Care, Florence, Italy. 5. ICoN Center, University Institute for Advanced Studies IUSS Pavia, Pavia, Italy. 6. IRCCS Mondino Foundation, Pavia, Italy. 7. Health Search, Italian College of General Practitioners and Primary Care, Via del Sansovino 179, 50141, Florence, Italy. lapi.francesco@simg.it.
Abstract
BACKGROUND: The exploitation of routinely collected clinical health information is warranted to optimize the case detection and diagnostic workout of Alzheimer's disease (AD). We aimed to derive an AD prediction score based on routinely collected primary care data. METHODS: We built a cohort selecting 199,978 primary care patients 60 + part of the Health Search Database between January 2002 and 2009, followed up until 2019 to detect incident AD cases. The cohort was randomly divided into a derivation and validation sub-cohort. To identify AD and non-AD cases, we applied a clinical algorithm that involved two clinicians. According to a nested case-control design, AD cases were matched with up to 10 controls based on age, sex, calendar period, and follow-up duration. Using the derivation sub-cohort, 32 potential AD predictors (sociodemographic, clinical, drug-related, etc.) were tested in a logistic regression and selected to build a prediction model. The predictive performance of this model was tested on the validation sub-cohort by mean of explained variation, calibration, and discrimination measurements. RESULTS: We identified 3223 AD cases. The presence of memory disorders, hallucinations, anxiety, and depression and the use of NSAIDs were associated with future AD. The combination of the predictors allowed the production of a predictive score that showed an explained variation (pseudo-R2) for AD occurrence of 13.4%, good calibration parameters, and an area under the curve of 0.73 (95% CI: 0.71-0.75). In accordance with this model, 7% of patients presented with a high-risk score for developing AD over 15 years. CONCLUSION: An automated risk score for AD based on routinely collected clinical data is a promising tool for the early case detection and timely management of patients by the general practitioners.
BACKGROUND: The exploitation of routinely collected clinical health information is warranted to optimize the case detection and diagnostic workout of Alzheimer's disease (AD). We aimed to derive an AD prediction score based on routinely collected primary care data. METHODS: We built a cohort selecting 199,978 primary care patients 60 + part of the Health Search Database between January 2002 and 2009, followed up until 2019 to detect incident AD cases. The cohort was randomly divided into a derivation and validation sub-cohort. To identify AD and non-AD cases, we applied a clinical algorithm that involved two clinicians. According to a nested case-control design, AD cases were matched with up to 10 controls based on age, sex, calendar period, and follow-up duration. Using the derivation sub-cohort, 32 potential AD predictors (sociodemographic, clinical, drug-related, etc.) were tested in a logistic regression and selected to build a prediction model. The predictive performance of this model was tested on the validation sub-cohort by mean of explained variation, calibration, and discrimination measurements. RESULTS: We identified 3223 AD cases. The presence of memory disorders, hallucinations, anxiety, and depression and the use of NSAIDs were associated with future AD. The combination of the predictors allowed the production of a predictive score that showed an explained variation (pseudo-R2) for AD occurrence of 13.4%, good calibration parameters, and an area under the curve of 0.73 (95% CI: 0.71-0.75). In accordance with this model, 7% of patients presented with a high-risk score for developing AD over 15 years. CONCLUSION: An automated risk score for AD based on routinely collected clinical data is a promising tool for the early case detection and timely management of patients by the general practitioners.
Authors: Andrea Ganna; Marie Reilly; Ulf de Faire; Nancy Pedersen; Patrik Magnusson; Erik Ingelsson Journal: Am J Epidemiol Date: 2012-03-06 Impact factor: 4.897
Authors: Valery L Feigin; Theo Vos; Emma Nichols; Mayowa O Owolabi; William M Carroll; Martin Dichgans; Günther Deuschl; Priya Parmar; Michael Brainin; Christopher Murray Journal: Lancet Neurol Date: 2019-12-05 Impact factor: 44.182
Authors: Elizabeth Ford; Nicholas Greenslade; Priya Paudyal; Stephen Bremner; Helen E Smith; Sube Banerjee; Shanu Sadhwani; Philip Rooney; Seb Oliver; Jackie Cassell Journal: PLoS One Date: 2018-03-29 Impact factor: 3.240